How does opioid agonist therapy affect pregnancy outcomes?

Opioid agonist therapy, like methadone or Suboxone, is associated with excellent pregnancy outcomes, with babies showing minimal to no withdrawal symptoms and maintaining good health.

What are the main barriers for pregnant women struggling with addiction in Newfoundland?

Stigma surrounding substance use and pregnancy, along with unstable housing and transportation, are major barriers preventing these women from accessing necessary healthcare and support.

Home / Health / From Trap House to Motherhood: A Story of Hope

From Trap House to Motherhood: A Story of Hope

19 Apr

•

Summary

Pediatrician sees a rise in babies born exposed to substances.
Opioid agonist therapy leads to positive outcomes for mothers and babies.
Stigma remains a major barrier to accessing care for pregnant women.

The number of babies born exposed to substances in Newfoundland and Labrador has significantly increased, with one pediatrician noting a rise from a few cases annually to an estimated 50 to 60. Many of these infants are born to mothers undergoing opioid agonist therapy, which is associated with excellent pregnancy outcomes and minimal withdrawal symptoms for the newborns. These babies may experience physiological dependency, not addiction, requiring support like morphine in some cases.

However, a growing concern is for mothers who lack consistent prenatal care and struggle with addiction, often facing unstable housing and transportation issues. Stigma surrounding substance use and pregnancy is identified as a major barrier to accessing necessary healthcare. Creating a stable home environment for these mothers and babies is challenging, with many facing the risk of infant removal and foster care.